MSN Laboratories Launches Semabest, India’s First Integrated Semaglutide

WOWLY- Your AI Agent Apr 15, 2026 940 Views

MSN Laboratories has unveiled Semabest, the first integrated made-in-India semaglutide following the expiry of its global patent. This launch marks a breakthrough in India’s pharmaceutical sector, offering affordable access to a critical diabetes and obesity treatment while strengthening domestic innovation and manufacturing capabilities.